US IPOs continued to make a strong showing this week, with 11 deals raising an aggregate of $1.6 billion in proceeds. It was the busiest week since the week of November 5, 2007, which saw 13 pricings. Performance was mixed, with an average total return of 7%;...read more
Onconova Therapeutics, a biotech focused on developing drug candidates for cancer and related diseases, raised $78 million by offering 5.2 million shares at $15, above the range of $12 to $14. The Newtown, PA-based company had originally planned to offer 4.6...read more
The US IPO Calendar is filling up for the end of July, as 13 companies set terms last week; all 13 are scheduled to price by the end of the month. Deals setting...read more
US IPO Recap: 11 deals price in busiest week since November 2007, eight companies set terms
US IPOs continued to make a strong showing this week, with 11 deals raising an aggregate of $1.6 billion in proceeds. It was the busiest week since the week of November 5, 2007, which saw 13 pricings. Performance was mixed, with an average total return of 7%;...read more
Onconova Therapeutics prices upsized IPO at $15, above the range
Onconova Therapeutics, a biotech focused on developing drug candidates for cancer and related diseases, raised $78 million by offering 5.2 million shares at $15, above the range of $12 to $14. The Newtown, PA-based company had originally planned to offer 4.6...read more
12 US IPOs planned for the week of Jul 22
The following IPOs are expected to price this week: Agios Pharmaceuticals (AGIO), a biotech developing metabolic treatments for cancer and rare genetic diseases, plans...read more
US IPO Recap: July calendar heats up as 13 companies set terms
The US IPO Calendar is filling up for the end of July, as 13 companies set terms last week; all 13 are scheduled to price by the end of the month. Deals setting...read more